FGF2 and cancer: Due to preferential binding of FGF2 and FGF4 to the IIIc-isoforms of FGFRs, the cancer cells expressing IIIc isoforms of FGFRs become sensitive to FGF2 and FGF4, which are abundant in stromal tissues.